STIL.CN)(FRANKFURT:A2PEWA) („STIL” or the „Company„) is pleased to announce it has received from the Ministry of Health and the Anti-Drug Agency its two most critical operational documents required for its Romania extraction operations.
https://youtu.be/ZzLdWlRhdjo].” data-reactid=”14″>A short video of the facility is available here [https://youtu.be/ZzLdWlRhdjo].
On the regional level, the final resolution approving the completion of construction has been issued. Risk Assessment and Security Project have both received approval from the local law enforcement authorities.
The operational environmental application has received internal endorsement from the Environmental Protection Agency and is entering the final public consultation phase, a two-week period in line with Romanian environmental law. The operational emergency services application has been submitted and site visits have been completed, during which no material remedial actions were requested. Final approval from the Emergency Services Unit is expected shortly.
With the ministerial documents in hand, and in accordance with municipal procedures, final operational permit is expected to be issued, by the local town hall after the mandatory two-week period.
www.Stillcanna.com is a Canadian early-stage life sciences company focused on the large scale manufacturing of CBD in Europe. The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences Ltd, a United Kingdom-based supplier of CBD. The Company also completed the acquisition of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is expected to increase the Company’s market share in the European CBD industry.” data-reactid=”21″>Stillcanna Inc. (STIL.CN) www.Stillcanna.com is a Canadian early-stage life sciences company focused on the large scale manufacturing of CBD in Europe. The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences Ltd, a United Kingdom-based supplier of CBD. The Company also completed the acquisition of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is expected to increase the Company’s market share in the European CBD industry.
Jason Dussault, CEO
Mauricio@Stillcanna.com
1(844)-442-STILL (7845)
